SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEssentra Regulatory News (ESNT)

Share Price Information for Essentra (ESNT)

Share Price is delayed by 15 minutes
Get Live Data
86.00    0.80 (0.94%)
Bid:
85.40
Ask:
86.00
Spread: 0.60 (0.703%)
Market Cap: £240.97m
ESNT Live PriceLast checked at - London Stock Exchange

Intraday Essentra Share Chart

Director/PDMR Shareholding

26 May 2023 14:27

RNS Number : 8559A
Essentra plc
26 May 2023
 

Essentra plc (the "Company")

Director/PDMR Notification

Notification and public disclosure of transactions by persons discharging

managerial responsibilities and persons closely associated with them

The notification made on behalf of Persons Discharging Managerial Responsibility ('PDMRs') under article 19.1 of the UK Market Abuse Regulation ('MAR') relates to transactions made on behalf PDMRs, in the Company.

On 31 March 2023, awards granted in 2020 under the Company's Deferred Annual Share Bonus Plan vested in full for two PDMRs.

The Company has been advised that some of the shares released to the PDMRs were subsequently disposed of on 31 March 2023, as indicated below at a share price of £1.922.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Scott Fawcett

Oshin Cassidy

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

 

Scott Fawcett

CEO

Oshin Cassidy

Group HR Director

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Essentra plc

b)

 

LEI

 

 

5493007MOZNA03BVNE96

 

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary 25p shares

Identification code

GB00B0744359

 

 

b)

 

Nature of the transaction

 

Vesting of awards granted on 30 March 2020 under the Deferred Annual Share Bonus Plan and sale of resulting shares to cover the tax liability due on the vesting.

 

 

c)

Price(s) and volume(s)

Name

Vesting Date

Price (£)

Shares vested

Shares sold to cover tax liability

Balance of shares to be retained

Scott Fawcett

March 2023

 

£1.922

9,586

4,325

5,261

Oshin Cassidy

March 2023

 

£1.922

8,553

3,860

4,693

d)

 

Aggregated information

- Aggregated volume

8,185

- Price

1.922

e)

 

Date of the transaction

 

31 March 2023

f)

 

Place of the transaction

 

London Stock Exchange (XLON)

 

Enquiries

 

Emma Reid

Company Secretary

T: 01908 359100

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHPPUCPAUPWGWQ
Date   Source Headline
10th Jun 20269:47 amRNSHolding(s) in Company
1st Jun 20267:00 amRNSTotal Voting Rights
29th May 20262:32 pmRNSTransaction in Own Shares
21st May 202610:55 amRNSResult of AGM
20th May 20267:00 amRNSAcquisition of Boteco Srl
20th May 20267:00 amRNS2026 AGM Trading Update
14th May 20265:15 pmRNSDirector/PDMR Shareholding
12th May 20267:03 amRNSTransaction in Own Shares
1st May 202612:17 pmRNSTotal Voting Rights
29th Apr 20268:12 amRNSTransaction in Own Shares
28th Apr 20263:25 pmRNSDirector/PDMR Shareholding
24th Apr 20263:30 pmRNSDirector/PDMR Shareholding
22nd Apr 20268:15 amRNSTransaction in Own Shares
21st Apr 20264:09 pmRNSDirector/PDMR Shareholding
17th Apr 20267:52 amRNSHolding(s) in Company
15th Apr 202610:06 amRNSDirector/PDMR Shareholding
15th Apr 20268:24 amRNSTransaction in Own Shares
15th Apr 20268:18 amRNSHolding(s) in Company
9th Apr 20268:24 amRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSHolding(s) in Company
1st Apr 20264:45 pmRNSDirector/PDMR Shareholding
1st Apr 20263:21 pmRNSDirector/PDMR Shareholding
1st Apr 20263:15 pmRNSTransaction in Own Shares
1st Apr 20263:08 pmRNSTotal Voting Rights
30th Mar 20262:00 pmRNSAnnual Financial Report
24th Mar 202610:05 amRNSTransaction in Own Shares
24th Mar 20268:17 amRNSHolding(s) in Company
19th Mar 20268:43 amRNSDirector/PDMR Shareholding
17th Mar 20261:41 pmRNSDirector/PDMR Shareholding
17th Mar 202610:30 amRNSDirectorate change
17th Mar 202610:28 amRNSDirector/PDMR Shareholding
17th Mar 20267:00 amRNSResults for the Full Year Ended 31 December 2025
17th Mar 20267:00 amRNSResults for the Full Year Ended 31 December 2025
16th Mar 20269:40 amRNSTransaction in Own Shares
16th Mar 20269:40 amRNSTransaction in Own Shares
13th Mar 202612:00 pmRNSCompany Secretary Change
9th Mar 20269:00 amRNSNotice of Full Year 2025 Results
9th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTotal Voting Rights
26th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:58 amRNSHolding(s) in Company
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 202612:20 pmRNSHolding(s) in Company
17th Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.